πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7906530

1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7897617

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7893087

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7888384

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7887789

Polymer derivatives having particular atom arrangements

Nektar Therapeutics Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7884119

Triazole derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7884234

N-phenyloxamide derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7879879

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7879874

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7879801

Compositions comprising cell-impermeant duramycin derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7875637

Benzimidazole derivative and use as a II receptor antagonist

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863275

Uses of tetrahydrobiopterin and derivatives thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7858583

Process for purifying glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7855220

Bicyclic derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7855202

Imidazopyridine derivatives as A2B adenosine receptor antagonists

Laboratories Almirall, S.A. Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7846954

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7842701

Pyrazoloquinolone derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7842819

Derivatives for modulation of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7838691

Palmerolides: methods of preparation and derivatives thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7834005

Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related th

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7829583

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7829712

Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

Xenon Pharmaceuticals Inc. Β· Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7825278

Substituted enaminones, their derivatives and uses thereof

The Regents of the University of California Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7825216

Phenylanine derivatives

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted